Success Metrics

Completion Rate
0%(0/1)
Active Trials
4(40%)
Terminated
1(10%)

Phase Distribution

Ph phase_2
3
30%
Ph phase_3
3
30%
Ph phase_1
4
40%

Phase Distribution

4

Early Stage

3

Mid Stage

3

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
4(40.0%)
Phase 2Efficacy & side effects
3(30.0%)
Phase 3Large-scale testing
3(30.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

4

trials recruiting

Total Trials

10

all time

Status Distribution
Active(7)
Terminated(1)
Other(2)

Detailed Status

Recruiting4
Not yet recruiting3
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
4
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (40.0%)
Phase 23 (30.0%)
Phase 33 (30.0%)

Trials by Status

recruiting440%
not_yet_recruiting330%
terminated110%
unknown220%

Recent Activity

Clinical Trials (10)

Showing 10 of 10 trials

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10